Systematic review of Pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer Review uri icon

Overview

MeSH Major

  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • There is little evidence that calculation of PSA velocity or doubling time in untreated patients provides predictive information beyond that provided by absolute PSA level alone. We see no justification for the use of PSA dynamics in clinical decision making before treatment in early-stage prostate cancer.

publication date

  • January 20, 2009

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC2645854

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.18.1685

PubMed ID

  • 19064972

Additional Document Info

start page

  • 398

end page

  • 403

volume

  • 27

number

  • 3